Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Schroll Medical ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.0% 2.4% 3.0% 1.9% 1.0% 0.5% 14.2% 14.1%   Credit score (0-100)   0 64 57 68 85 99 15 16   Credit rating   N/A BBB BBB A A AAA BB BB   Credit limit (kDKK)   0.0 0.1 0.0 10.8 3,465.4 7,865.1 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 -103 -31.4 10,713 20,124 30,414 0.0 0.0   EBITDA   0.0 -103 -31.4 -2,764 4,949 14,373 0.0 0.0   EBIT   0.0 -103 -3,031 -8,046 -4,331 3,209 0.0 0.0   Pre-tax profit (PTP)   0.0 -227.3 -3,204.3 -8,275.9 -4,563.3 3,027.7 0.0 0.0   Net earnings   0.0 -147.8 -2,022.5 -5,230.8 -3,108.3 2,442.5 0.0 0.0   Pre-tax profit without non-rec. items   0.0 -227 -3,204 -8,276 -4,563 3,028 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   0.0 13,772 3,089 2,869 3,725 5,646 0.0 0.0   Shareholders equity total   0.0 19,852 27,830 52,599 69,491 71,933 -29,322 -29,322   Interest-bearing liabilities   0.0 8,342 11,714 5,501 5,811 0.0 29,322 29,322   Balance sheet total (assets)   0.0 32,390 46,981 71,596 89,747 88,167 0.0 0.0   Net Debt   0.0 8,342 11,653 4,921 5,805 -247 29,322 29,322     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 -103 -31.4 10,713 20,124 30,414 0.0 0.0   Gross profit growth   0.0% 0.0% 69.4% 0.0% 87.8% 51.1% -100.0% 0.0%   Employees   0 6 25 34 36 38 0 0   Employee growth %   0.0% 0.0% 316.7% 36.0% 5.9% 5.6% -100.0% 0.0%   Employee expenses   0.0 -6,707.0 -17,933.2 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 32,390 46,981 71,596 89,747 88,167 0 0   Balance sheet change%   0.0% 0.0% 45.0% 52.4% 25.4% -1.8% -100.0% 0.0%   Added value   0.0 6,604.4 17,901.8 -2,763.9 950.6 14,372.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 28,772 -9,183 8,549 -9,800 -14,168 -32,896 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 -1.0 -2.0 -3.0 -4.0 1.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 100.0% 9,664.5% -75.1% -21.5% 10.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% -0.3% -7.6% -13.6% -5.4% 3.6% 0.0% 0.0%   ROI %   0.0% -0.3% -8.0% -14.4% -5.7% 3.9% 0.0% 0.0%   ROE %   0.0% -0.7% -8.5% -13.0% -5.1% 3.5% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   0.0% 61.3% 59.2% 73.5% 77.4% 81.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -8,137.8% -37,151.2% -178.0% 117.3% -1.7% 0.0% 0.0%   Gearing %   0.0% 42.0% 42.1% 10.5% 8.4% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 3.0% 1.9% 2.7% 4.4% 6.2% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   0.0 0.4 0.5 1.2 1.2 1.3 0.0 0.0   Current Ratio   0.0 0.4 1.8 3.3 4.8 8.3 0.0 0.0   Cash and cash equivalent   0.0 0.0 61.6 580.0 5.4 247.3 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 -6,308.2 10,678.6 24,618.9 42,575.7 48,608.0 -14,661.1 -14,661.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 1,101 716 -81 26 378 0 0   Employee expenses / employee   0 -1,118 -717 0 0 0 0 0   EBITDA / employee   0 -17 -1 -81 137 378 0 0   EBIT / employee   0 -17 -121 -237 -120 84 0 0   Net earnings / employee   0 -25 -81 -154 -86 64 0 0